Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 244, pseudogene (RN7SL244P) is a processed pseudogene that is homologous to the functional 7SL RNA gene. The 7SL RNA encodes the RNA component of the signal recognition particle (SRP), which is involved in targeting proteins to the endoplasmic reticulum in eukaryotic cells[1][3]. Unlike the canonical 7SL RNA genes, RN7SL244P does not produce a functional RNA and is not known to play a direct role in cellular physiology. Many such pseudogenes arise from reverse transcription events and are scattered throughout the genome, often truncated and non-functional[5]. While some pseudogenes can influence cell biology by acting as competitive endogenous RNAs (ceRNAs) or altering parental gene regulation, there is no published evidence that RN7SL244P possesses these roles[4]. RN7SL244P is therefore considered a non-functional genomic element with no direct relevance as a therapeutic target, biomarker, or drug-interaction molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 244, pseudogene (RN7SL244P).